BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 142 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2017. The put-call ratio across all filers is 0.76 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $4,377,054 | -56.6% | 40,611 | -62.0% | 0.45% | -50.9% |
| Q2 2019 | $10,089,000 | +69.3% | 106,956 | +43.7% | 0.92% | +73.9% |
| Q1 2019 | $5,960,000 | +56.1% | 74,451 | +52.2% | 0.53% | +73.9% |
| Q3 2018 | $3,819,000 | +21.9% | 48,921 | -0.9% | 0.31% | +39.1% |
| Q2 2018 | $3,133,000 | -1.1% | 49,362 | +42.8% | 0.22% | -3.1% |
| Q1 2018 | $3,169,000 | -44.3% | 34,556 | -54.2% | 0.23% | +20.7% |
| Q4 2017 | $5,694,000 | +118.6% | 75,510 | +101.9% | 0.19% | +4.4% |
| Q3 2017 | $2,605,000 | +37.6% | 37,394 | +0.2% | 0.18% | +34.3% |
| Q2 2017 | $1,893,000 | +115.6% | 37,337 | +69.7% | 0.13% | +116.1% |
| Q1 2017 | $878,000 | – | 21,998 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 581,768 | $25,487,256 | 9.57% |
| Casdin Capital, LLC | 1,477,800 | $64,742,418 | 5.02% |
| Nextech Invest Ltd. | 188,228 | $8,246,269 | 3.28% |
| DAFNA Capital Management LLC | 261,235 | $11,444,705 | 3.22% |
| Rock Springs Capital Management LP | 1,891,510 | $82,867,053 | 1.99% |
| HealthCor Management, L.P. | 30,000 | $1,314,300 | 1.20% |
| EFG Asset Management (North America) Corp. | 110,853 | $4,766,679 | 1.07% |
| Novo Holdings A/S | 370,000 | $16,209,700 | 1.01% |
| SECTORAL ASSET MANAGEMENT INC | 115,900 | $5,077,579 | 0.98% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 305,709 | $13,393,111 | 0.83% |